Justin Burgess Sells $36.7K of Dynavax Technologies Corp (DVAX) — SEC Form 4, Mar 26, 2021

Open-Market Net Sale · SEC Form 4
−$36,728

Equity position changed by +123.2%

Reporting Owner
TXN 2021-03-02 · FILED 2021-03-26
Equity Position 11.1K sh 4,989 → 11,133
Equity Change +123.2% shares held after vs before
Filing Lag 18 business days late vs 2-day SEC deadline
Form 4 · Statement of Changes in Beneficial Ownership
Filing Date
2021-03-26
Report Date
2021-02-26
Accession No.
0001209191-21-023324
Accepted At
2021-03-26 18:46 UTC
Reporting Owner
Name Relationship
Justin Burgess CIK 0001812025
CAO
Justin Burgess at Dynavax Technologies Corp Full insider history
Bought (12 mo) —
Sold (12 mo) —
More from this insider at Dynavax Technologies Corp
2025-02-12 Exercise — View
2024-03-19 Award — View
2024-03-04 Sell -$262,322 View
2024-02-20 Exercise — View
2024-02-13 Exercise — View
All filings by this insider at Dynavax Technologies Corp
Non-Derivative Securities Transactions
Title Date Type Shares Price Net Total Post-Txn Ownership
Common StockF4 2021-03-01 M - Exercise 2,839 A — 11,133 Direct
Common StockF5 2021-03-01 S - Sale 1,325 D $8.88 -$11,766 9,808 Direct
Common StockF6 2021-03-01 S - Sale 1,633 D $8.88 -$14,501 8,175 Direct
Common StockF7 2021-03-02 S - Sale 1,186 D $8.82 -$10,461 6,989 Direct
Common StockF3 2021-02-26 M - Exercise 3,906 A — 8,294 Direct
Common StockF1 2021-02-12 A - Award/Grant 376 A $3.39 +$1,275 1,221 Direct
Common StockF2 2021-02-26 M - Exercise 3,167 A — 4,388 Direct
Derivative Securities Transactions
Title Strike Date Type Shares Price Expiration Underlying Ownership
Restricted Stock UnitF2F2F2F2 2021-02-26 M - Exercise 3,167 D 3,167 Common Stock Direct
Restricted Stock UnitF3F3F3F3 2021-02-26 M - Exercise 3,906 D 3,906 Common Stock Direct
Restricted Stock UnitF4F4F4F4 2021-03-01 M - Exercise 2,839 D 2,839 Common Stock Direct
Footnotes (7)
F1
Represents 376 shares acquired under Issuer's 2014 Employee Stock Purchase Plan (ESPP) on February 12, 2021 Show more
F2
Each RSU represents a contingent right to receive one share of common stock. The RSUs vest over three years with 1/3 vesting on each annual anniversary of February 12, 2020. Delivery of the shares in settlement of the RSUs was deferred to February 26, 2021. Show more
F3
Each RSU represents a contingent right to receive one share of common stock. The RSUs vest over three years with 1/3 vesting on each annual anniversary of February 22, 2019. Delivery of the shares in settlement of the RSUs was deferred to February 26, 2021. Show more
F4
Each Restricted Stock Unit ("RSU") represents a contingent right to receive one share of common stock. The RSUs vest over three years with 1/3 vesting on each annual anniversary of March 1, 2018. Show more
F5
The reporting person is reporting the sale of 1,325 shares of common stock to satisfy the reporting person's tax withholding obligations in connection with the delivery of common stock to the reporting person on February 26, 2021. Show more
F6
The reporting person is reporting the sale of 1,633 shares of common stock to satisfy the reporting person's tax withholding obligations in connection with the delivery of common stock to the reporting person on February 26, 2021. Show more
F7
The reporting person is reporting the sale of 1,186 shares of common stock to satisfy the reporting person's tax withholding obligations in connection with the delivery of common stock to the reporting person on March 1, 2021. Show more
Remarks

This amendment to Form 4 is being filed solely to correct the number of shares reflected as being sold in footnote 7 to the Form 4 filed on March 2, 2021, from 1,165 shares to 1,186 shares.

Show more
5%+ Holders · 13D/G 1 filer
Other insiders at Dynavax Technologies Corp
All Dynavax Technologies Corp insider activity
GET /v1/forms/4/0001209191-21-023324 API docs
View Original SEC Filing